Tetanus and Diphtheria Seroprotection among Children Younger Than 15 Years in Nigeria, 2018: Who Are the Unprotected Children?

Serological surveys provide an objective biological measure of population immunity, and tetanus serological surveys can also assess vaccination coverage. We undertook a national assessment of immunity to tetanus and diphtheria among Nigerian children aged <15 years using stored specimens collected during the 2018 Nigeria HIV/AIDS Indicator and Impact Survey, a national cross-sectional household-based survey. We used a validated multiplex bead assay to test for tetanus and diphtheria toxoid-antibodies. In total, 31,456 specimens were tested. Overall, 70.9% and 84.3% of children aged <15 years had at least minimal seroprotection (≥0.01 IU/mL) against tetanus and diphtheria, respectively. Seroprotection was lowest in the north west and north east zones. Factors associated with increased tetanus seroprotection included living in the southern geopolitical zones, urban residence, and higher wealth quintiles (p < 0.001). Full seroprotection (≥0.1 IU/mL) was the same for tetanus (42.2%) and diphtheria (41.7%), while long-term seroprotection (≥1 IU/mL) was 15.1% for tetanus and 6.0% for diphtheria. Full- and long-term seroprotection were higher in boys compared to girls (p < 0.001). Achieving high infant vaccination coverage by targeting specific geographic areas and socio-economic groups and introducing tetanus and diphtheria booster doses in childhood and adolescence are needed to achieve lifelong protection against tetanus and diphtheria and prevent maternal and neonatal tetanus.

[1]  A. Tatem,et al.  Mapping the distribution of zero-dose children to assess the performance of vaccine delivery strategies and their relationships with measles incidence in Nigeria , 2022, medRxiv.

[2]  J. Mosser,et al.  Factors consistently associated with utilisation of essential maternal and child health services in Nigeria: analysis of the five Nigerian national household surveys (2003–2018) , 2022, BMJ Open.

[3]  A. Tatem,et al.  Multilevel analysis of predictors of multiple indicators of childhood vaccination in Nigeria , 2022, PloS one.

[4]  Nicole A. Hoff,et al.  Tetanus seroprotection among children in the Democratic Republic of the Congo, 2013–2014 , 2022, PloS one.

[5]  M. Levine,et al.  Linked vaccination coverage surveys plus serosurveys among Ethiopian toddlers undertaken three years apart to compare coverage and serologic evidence of protection in districts implementing the RED-QI approach , 2021, Vaccine.

[6]  Heather M. Scobie,et al.  Validation of a diphtheria toxoid multiplex bead assay for serosurveys. , 2021, Diagnostic microbiology and infectious disease.

[7]  J. Ostermann,et al.  Parental concerns and uptake of childhood vaccines in rural Tanzania – a mixed methods study , 2020, BMC Public Health.

[8]  P. Adrien,et al.  Seroprevalence of Measles, Rubella, Tetanus, and Diphtheria Antibodies among Children in Haiti, 2017. , 2020, The American journal of tropical medicine and hygiene.

[9]  Antoine Durupt,et al.  Status of the Rollout of the Meningococcal Serogroup A Conjugate Vaccine in African Meningitis Belt Countries in 2018 , 2019, The Journal of infectious diseases.

[10]  E. Mworozi,et al.  Barriers to effective uptake and provision of immunization in a rural district in Uganda , 2019, PloS one.

[11]  Heather M. Scobie,et al.  Integrated Serologic Surveillance of Population Immunity and Disease Transmission , 2018, Emerging infectious diseases.

[12]  P. Offit,et al.  Plotkin's Vaccines , 2017 .

[13]  Heather M. Scobie,et al.  Tetanus Immunity Gaps in Children 5-14 Years and Men ≥ 15 Years of Age Revealed by Integrated Disease Serosurveillance in Kenya, Tanzania, and Mozambique. , 2017, The American journal of tropical medicine and hygiene.

[14]  Y. Woldeamanuel,et al.  Case fatality of adult tetanus in Africa: Systematic review and meta-analysis , 2016, Journal of the Neurological Sciences.

[15]  F. Cutts,et al.  Seroepidemiology: an underused tool for designing and monitoring vaccination programmes in low‐ and middle‐income countries , 2016, Tropical medicine & international health : TM & IH.

[16]  R. Baggaley,et al.  Tetanus disease and deaths in men reveal need for vaccination , 2016, Bulletin of the World Health Organization.

[17]  K. Wannemuehler,et al.  Tetanus Immunity among Women Aged 15 to 39 Years in Cambodia: a National Population-Based Serosurvey, 2012 , 2016, Clinical and Vaccine Immunology.

[18]  C Jessica E Metcalf,et al.  Use of serological surveys to generate key insights into the changing global landscape of infectious disease , 2016, The Lancet.

[19]  James D. Campbell,et al.  Immunization Coverage Surveys and Linked Biomarker Serosurveys in Three Regions in Ethiopia , 2016, PloS one.

[20]  N. Basta,et al.  Higher Tetanus Toxoid Immunity 2 Years After PsA-TT Introduction in Mali , 2015, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[21]  Yuxiao Tang,et al.  MenAfriVac as an Antitetanus Vaccine , 2015, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[22]  V. Dietz,et al.  Issues and considerations in the use of serologic biomarkers for classifying vaccination history in household surveys. , 2014, Vaccine.

[23]  K. Porten,et al.  Diphtheria outbreak with high mortality in northeastern Nigeria , 2013, Epidemiology and Infection.

[24]  R. Oladokun,et al.  Re-emergence of diphtheria and pertussis: implications for Nigeria. , 2012, Vaccine.

[25]  Richard G Pebody,et al.  Immunity to tetanus and diphtheria in the UK in 2009. , 2012, Vaccine.

[26]  A. Glatman-Freedman,et al.  The effect of social determinants on immunization programs , 2012, Human vaccines & immunotherapeutics.

[27]  M. Préziosi,et al.  The Meningitis Vaccine Project. , 2007, Vaccine.

[28]  K. Kjeldsen,et al.  Immunity to tetanus and diphtheria in rural Africa. , 1997, The American journal of tropical medicine and hygiene.

[29]  K. A. Harrison,et al.  Trade Flows and Employment Outcomes in Nigeria , 2010 .

[30]  J. Meigs,et al.  WHO Technical Report , 1954, The Yale Journal of Biology and Medicine.

[31]  Module,et al.  The Immunological Basis for Immunization Series , 2000 .

[32]  Epidemic meningitis control in countries of the African meningitis belt, 2016. , 2017, Releve epidemiologique hebdomadaire.

[33]  The immunological basis for immunization series Module , 2009 .

[34]  M. Deming,et al.  Tetanus toxoid coverage as an indicator of serological protection against neonatal tetanus. , 2002, Bulletin of the World Health Organization.

[35]  Tigran Nikoghosyan,et al.  United Nations Children’s Fund (UNICEF) , 2018, Yearbook of International Cooperation on Environment and Development 1998–99.